ClariVest Asset Management LLC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 176 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.7%.

Quarter-by-quarter ownership
ClariVest Asset Management LLC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$423,000
-5.4%
16,430
-4.0%
0.01%
-6.7%
Q2 2021$447,000
+22.8%
17,108
+65.7%
0.02%
+15.4%
Q1 2021$364,000
+67.0%
10,324
+19.7%
0.01%
+85.7%
Q4 2020$218,000
-71.6%
8,623
-57.6%
0.01%
-72.0%
Q3 2020$768,000
-15.9%
20,355
-4.5%
0.02%0.0%
Q2 2020$913,00021,3070.02%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$26,829,00010.04%
Wildcat Capital Management, LLC 1,716,370$25,608,0004.17%
TPG GP A, LLC 18,716,306$279,247,0002.79%
Casdin Capital, LLC 2,650,000$39,538,0001.11%
Lombard Odier Asset Management (Switzerland) SA 996,116$14,862,0000.95%
Coastal Bridge Advisors, LLC 301,929$4,505,0000.94%
HARBOR CAPITAL ADVISORS, INC. 119,547$1,784,0000.65%
Pier Capital, LLC 294,968$4,401,0000.46%
Navalign, LLC 64,428$961,0000.38%
Gratus Capital, LLC 191,871$2,863,0000.26%
View complete list of ALLOGENE THERAPEUTICS INC shareholders